Bio-Techne Q3 FY26: where the revenue came from and where it went
The whole income statement of Bio-Techne for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jan 1 – Mar 31, 2026
- Reported
- May 6, 2026
Revenue$0.31B
−2% year over year
Gross profit$0.21B
67% margin
Operating profit$0.08B
24% margin
Net profit$0.05B
16% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 0.31 | 100% | −2% |
| Consumables | 0.26 | 83% | +0% |
| Instruments | 0.03 | 9% | +6% |
| Services | 0.02 | 7% | −21% |
| Royalty | 0.01 | 1% | −1% |
| Cost of revenue | −0.10 | 33% | |
| Gross profit | 0.21 | 67% margin | −1pp |
| SG&A | −0.11 | 35% | −13pp |
| Other | −0.02 | 8% | +0pp |
| Operating profit | 0.08 | 24% margin | +12pp |
| Interest & other costs | −<0.01 | ||
| Tax | −0.02 | ||
| Net profit | 0.05 | 16% margin | +9pp |
39 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest